Patient Monitoring Devices and Accessories Market Size and Forecast, 2026–2035

Patient Monitoring Devices & Accessories Market Size & Forecast

The global patient monitoring devices and accessories market is valued at USD 54.47 billion in 2025 and is projected to reach USD 109.33 billion by 2035, expanding at a compound annual growth rate of 7.20% from 2026 to 2035. Growth is being reshaped by the movement of physiological surveillance from intensive care units into general wards, outpatient pathways and the home.

Patient monitoring includes devices, software-enabled hardware and recurring accessories used to measure, display, transmit or analyze physiological parameters. Core measurements include electrocardiography, heart rate, blood pressure, blood glucose, oxygen saturation, respiration, temperature, cardiac output, blood gas, electroencephalography, anesthesia depth and fetal or neonatal parameters. The market includes bedside monitors, central stations, telemetry, wearable and ambulatory systems, remote-monitoring devices, sensors, cuffs, electrodes, cables, probes and related single-use components.

The category is wider than a hospital monitor mounted beside a bed. A connected blood glucose meter used in a remote care program, a wearable cardiac telemetry unit, a pulse-oximetry sensor in a step-down unit and a fetal monitor in a maternity ward all participate in different purchasing and reimbursement pathways. Product comparisons therefore need to account for clinical purpose, measurement accuracy, care setting, connectivity, data workflow and accessory consumption.

Hospital demand is moving from isolated hardware replacement toward enterprise monitoring architecture. Health systems want transport continuity, central surveillance, alarm management, device integration, cybersecurity and consistent parameters across departments. Philips introduced its Telemetry Monitor 5500 platform in 2025 to support continuous cardiac surveillance, mobile workflows and telemetry utilization analytics. GE HealthCare’s Carevance platform, which received CE marking in 2025, combines core vital signs with transport workflows and a software-based cardiac-output insight feature. These launches illustrate a market where software and operational workflow increasingly determine hardware selection.

Key Highlights

• Global revenue is calculated at USD 54.47 billion in 2025 and is forecast to reach USD 109.33 billion by 2035 at a 7.20% CAGR.
• Hemodynamic monitoring leads with 49.6% of revenue, supported by blood glucose, blood pressure, blood gas, electrolyte and advanced cardiac-output monitoring.
• Monitoring devices account for 68% of sales, while accessories and consumables hold 32% and provide a recurring revenue base.
• Hospitals and clinics generate 55% of revenue, but homecare has reached 24% through diabetes, cardiac, respiratory and post-discharge monitoring.
• Connected and wireless products represent 61% of sales, making interoperability, cybersecurity and data governance central to procurement.
• North America leads with 42.8% of revenue; Asia-Pacific is forecast to grow fastest as hospital capacity and remote-care access expand.
• Alarm burden, workflow integration and total accessory cost now influence purchases as strongly as the monitor’s parameter list.

Monitoring Architecture and Market Dynamics

Monitoring Is Expanding Beyond the Intensive Care Unit

Hospitals are extending continuous surveillance into emergency departments, medical-surgical wards and procedural recovery areas. The clinical objective is earlier detection of deterioration, but expansion creates new workflow problems. Each added bed increases alarms, data traffic, device maintenance and sensor consumption. A monitoring program can fail if staff receive more notifications without the ability to prioritize them.

Vendors are responding with early-warning scores, arrhythmia analysis, centralized monitoring and alarm-reduction algorithms. GE HealthCare states that the EK-Pro algorithm used in Carevance can reduce false ECG alarms substantially under validated conditions. Philips positions its telemetry platform around alarm filtering, operational analytics and mobile task support. The commercial opportunity is no longer defined only by monitor count; it includes software that helps a limited clinical workforce manage more monitored patients.

Remote Monitoring Depends on Exception Management

Remote patient monitoring expanded rapidly across diabetes, hypertension, cardiac rhythm, sleep-disordered breathing and post-discharge care. Connected devices can transmit measurements automatically, reducing reliance on handwritten logs. Cellular connectivity is useful for patients without reliable home Wi-Fi. Prevounce Health’s Pylo GL1-LTE glucose meter, launched in 2024, was designed to connect across multiple cellular networks and integrate through a cloud application interface.

Data transmission does not create clinical value by itself. Programs need enrollment, device setup, adherence tracking, threshold rules, escalation staff and documented action. A remote monitoring vendor that supplies hardware without workflow support can leave clinicians with a larger unreviewed data queue. Procurement is therefore moving toward device-platform-service combinations that define who reviews the measurement and what happens after an alert.

Accessories Drive Recurring Cost and Standardization

Electrodes, SpO2 sensors, blood-pressure cuffs, temperature probes, invasive pressure transducers, sampling lines, cables and batteries generate recurring demand. They also create hidden cost through incompatibility, skin injury, breakage and inventory complexity. A low monitor acquisition price can be offset by proprietary accessories used across thousands of patient days.

Hospitals increasingly standardize connector families, reusable versus disposable policies and approved alternatives. Infection prevention may favor single-patient-use products, while sustainability and cost targets encourage reusable accessories when cleaning is practical. Suppliers that document cleaning compatibility, material durability and signal performance can defend accessory pricing more effectively than those relying on proprietary lock-in.

Interoperability Has Become a Procurement Gate

Monitoring data must reach central stations, electronic health records, mobile devices and clinical decision-support systems. Health systems want consistent patient identity, synchronized timestamps, validated parameter mapping and minimal manual transcription. Integration projects can delay deployment even when the monitor itself is ready.

Open interfaces improve flexibility but require governance. Hospitals need to understand which system is the source of truth, how data gaps are handled and whether algorithm updates change displayed values. Vendors are judged on interface documentation, implementation resources and support across the installed IT environment. Monitor replacement is therefore often tied to a wider enterprise architecture decision.

Cybersecurity Extends Through the Device Lifecycle

Networked monitors can remain in service for a decade, creating exposure when operating systems, wireless standards or encryption requirements change. Hospitals assess software-update policy, vulnerability disclosure, asset inventory, authentication and the ability to segment devices on the network. Remote support connections and cloud dashboards add further access points.

Cybersecurity is not a one-time clearance task. Manufacturers need a process for coordinated vulnerability response and patches throughout the supported life. Buyers also need clarity on end-of-support dates because an otherwise functional monitor may become a security liability. This favors vendors with mature product-security programs and can accelerate fleet replacement.

Staffing Shortages Favor Usable, Not Merely Feature-Rich, Systems

Complex menus and inconsistent alarm logic increase cognitive load. Hospitals prioritize rapid admission, patient transfer, transport continuity, readable waveforms and clear alarm ownership. New platforms emphasize touchscreen workflows, parameter modules that move with the patient and centralized technical administration.

Mindray introduced the BeneVision V Series at Euroanaesthesia 2025 as a next-generation platform aimed at clinical decision support and workflow. GE HealthCare’s Carevance similarly emphasizes scalable parameters and intra-hospital transport. The commercial contest is shifting toward the number of steps required to perform routine tasks, not the number of functions listed in a brochure.

Reimbursement and Evidence Divide Home and Hospital Markets

Hospital monitoring is funded through capital budgets, procedure payments, consumable budgets and service contracts. Remote monitoring may depend on country-specific reimbursement, eligible conditions, documented data collection and clinician time. Consumer willingness to purchase a wearable does not establish a reimbursable medical pathway.

Suppliers must distinguish regulated clinical monitoring from wellness tracking. Accuracy across skin tone, motion, perfusion, age and disease state is critical for pulse oximetry and other optical parameters. Evidence must reflect the population and setting in which the device is used. Weak validation can prevent inclusion in clinical protocols even if the product is commercially available.

Market Scope and Forecast

Market Segmentation Analysis

By Product Type

Hemodynamic monitoring devices generated 49.6% of 2025 revenue, equal to USD 27.02 billion. This broad segment includes blood glucose systems, blood-pressure monitors, blood gas and electrolyte analyzers, invasive pressure monitoring and cardiac-output technologies. Diabetes monitoring represents a major share because devices and recurring sensors or test supplies create high annual expenditure. Perioperative hemodynamic monitoring also gains value as hospitals seek earlier management of hypotension.

Cardiac monitoring devices held 16%, or USD 8.72 billion, including bedside ECG, telemetry, Holter systems, mobile cardiac telemetry and insertable monitors. Respiratory monitoring accounted for 12%, equal to USD 6.54 billion, led by pulse oximetry, capnography, respiratory-rate monitoring and connected respiratory-care devices. Fetal and neonatal monitoring contributed 7%, or USD 3.81 billion.

Neuromonitoring represented 6%, valued at USD 3.27 billion, while anesthesia monitoring held 5%, or USD 2.72 billion. Temperature and other monitoring products supplied the remaining 4.4%, equal to USD 2.40 billion. Growth rates will differ: remote cardiac and glucose monitoring will outpace mature temperature and conventional bedside categories.

By Component

Monitoring devices and software-enabled hardware accounted for 68% of 2025 revenue, equal to USD 37.04 billion. This segment includes bedside and transport monitors, telemetry units, central stations, home devices and dedicated analyzers. Capital revenue is influenced by fleet-refresh cycles, new bed capacity and enterprise platform conversion.

Accessories and consumables held 32%, or USD 17.43 billion. Sensors, cuffs, electrodes, probes, cables, batteries, modules and sampling components provide recurring revenue and can exceed the original hardware cost over a monitor’s life. Single-use accessories are expected to grow faster where infection control and measurement consistency outweigh waste concerns.

By Connectivity

Connected and wireless systems represented 61% of 2025 sales, valued at USD 33.22 billion. The category includes networked hospital monitors, Bluetooth or Wi-Fi devices, cellular remote-monitoring products and systems connected through hubs. Their value lies in automatic transfer, central surveillance and longitudinal records.

Standalone or locally connected devices held 39%, or USD 21.25 billion. These products remain relevant in smaller facilities, transport, emergency preparedness and markets with limited network infrastructure. Standalone does not mean low clinical performance, but the lack of enterprise integration can restrict scaling.

By Monitoring Acuity

High-acuity and perioperative monitoring generated 39% of 2025 revenue, equal to USD 21.24 billion. Intensive care, operating rooms, anesthesia and emergency care require multi-parameter systems, invasive measurements and high-reliability accessories. General ward and step-down monitoring held 23%, or USD 12.53 billion, and is expanding through wireless telemetry and wearable vital-sign sensors.

Ambulatory and home monitoring accounted for 31%, equal to USD 16.89 billion, led by glucose, blood pressure, cardiac rhythm and respiratory care. Diagnostic and episodic monitoring represented 7%, or USD 3.81 billion. These categories overlap clinically, but the split reflects the primary care environment and purchasing pathway.

By End User

Hospitals and clinics controlled 55% of 2025 revenue, valued at USD 29.96 billion. Their share includes intensive care, operating rooms, wards, emergency departments, maternity and specialty clinics. Homecare accounted for 24%, or USD 13.07 billion, supported by chronic disease management and post-discharge programs.

Diagnostic centers held 9%, equal to USD 4.90 billion, while outpatient and ambulatory facilities represented another 9%, or USD 4.90 billion. Long-term care, emergency services and other users contributed 3%, equal to USD 1.63 billion. Homecare will gain share, but hospitals will remain the largest revenue pool because high-acuity systems and accessories command greater value per patient.

Regional and Country-Level Analysis

North America

North America led with 42.8% of 2025 revenue, equal to USD 23.31 billion. The United States represented 38% of the global market, or USD 20.70 billion, supported by high hospital technology intensity, diabetes monitoring, cardiac telemetry and remote-care reimbursement. Canada held 3.5%, equal to USD 1.91 billion, while Mexico accounted for 1.3%, or USD 0.71 billion.

U.S. procurement is moving toward enterprise standardization and measurable workflow returns. Health systems evaluate alarm performance, cybersecurity, interface cost, transport continuity and accessory expenditure. Home monitoring remains attractive, but reimbursement documentation and staffing determine whether programs generate sustained device use.

Europe

Europe accounted for 27% of 2025 revenue, valued at USD 14.71 billion. Germany held 6% of global revenue, or USD 3.27 billion; the United Kingdom represented 5%, or USD 2.72 billion; France contributed 4.5%, equal to USD 2.45 billion; Italy held 3.5%, or USD 1.91 billion; and Spain accounted for 2.5%, or USD 1.36 billion. Other European markets generated 5.5%, equal to USD 3.00 billion.

European demand combines hospital fleet modernization with connected chronic-care programs. Public tenders increase price pressure and favor interoperable platforms that can be standardized across sites. Medical-device regulation, cybersecurity, data protection and sustainability requirements influence product qualification. The 2025 CE marking of GE HealthCare’s Carevance platform illustrates continued investment in scalable monitoring designed for varied hospital budgets.

Asia-Pacific

Asia-Pacific captured 23% of 2025 revenue, equal to USD 12.53 billion, and is expected to grow fastest through 2035. China represented 7% of global sales, or USD 3.81 billion; India held 4.5%, equal to USD 2.45 billion; Japan accounted for 4%, or USD 2.18 billion; South Korea contributed 3%, or USD 1.63 billion; and other regional markets generated 4.5%, equal to USD 2.45 billion.

China combines hospital expansion with strong domestic monitoring manufacturers. India offers large demand for affordable multi-parameter and home devices, but service reach and hospital budget variation shape adoption. Japan prioritizes reliable hospital integration and aging-related home monitoring. Southeast Asia is expanding private hospital capacity while maintaining a price-sensitive public sector.

South America

South America generated 4% of 2025 revenue, equal to USD 2.18 billion. Brazil held 2.5% of the global market, or USD 1.36 billion, while Argentina and other countries contributed 1.5%, or USD 0.82 billion. Public tenders, local registration and currency volatility influence replacement cycles. Demand is strongest for scalable monitors with local technical service and affordable accessories.

Middle East and Africa

The Middle East and Africa held 3.2% of 2025 revenue, valued at USD 1.74 billion. Saudi Arabia, the United Arab Emirates, Türkiye, Israel and South Africa lead adoption. Gulf hospital investment supports enterprise monitoring, while many African markets prioritize durable multi-parameter systems and maternal or neonatal monitoring. Limited biomedical engineering support and consumable availability can restrict utilization after installation.

Competitive Landscape

Competition spans diversified medical technology companies, monitoring specialists and digital health platforms. Major participants include GE HealthCare, Philips, Mindray, Medtronic, Abbott, Dexcom, Masimo, Baxter, Edwards Lifesciences, Boston Scientific and Compumedics. The competitive set changes by modality: glucose monitoring is led by diabetes specialists, while hospital bedside monitoring is concentrated among enterprise platform vendors.

Purchasing power increasingly favors companies that can combine hardware, validated parameters, accessories, central surveillance, interfaces and lifecycle cybersecurity. Smaller firms can win through specialized algorithms or remote-care workflows, but they need integration partnerships and national service coverage to scale.

GE HealthCare Technologies Inc.

GE HealthCare competes through CARESCAPE, Portrait Mobile, central surveillance, clinical accessories and the newer Carevance platform. Its strategy is to create scalable architecture across transport, bedside and enterprise workflows while retaining validated parameters and proprietary algorithms. Carevance’s Cardiac Output Insights extends hemodynamic decision support through software rather than another invasive catheter. GE HealthCare described itself as a USD 20.6 billion business in its 2025 Carevance announcement, but patient-monitoring revenue is not separately disclosed; market analysis should not treat total company sales as monitoring sales.

Koninklijke Philips N.V.

Philips offers IntelliVue bedside monitors, central monitoring, wearable telemetry, mobile cardiac telemetry and enterprise informatics. The 2025 Telemetry Monitor 5500 launch targets continuous surveillance, alarm management and operational visibility across the hospital. Philips reported EUR 18 billion in 2024 company sales; standalone 2025 patient-monitoring revenue is not publicly separated from its wider health-technology portfolio. Its competitive advantage is the connection between bedside monitoring, telemetry, informatics and post-discharge cardiac services.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Mindray supplies BeneVision, BeneView and other monitoring platforms across critical care, perioperative and general hospital settings. The BeneVision V Series debut in 2025 strengthens its position in premium monitoring through upgraded workflow, clinical decision support and connectivity. Mindray’s global strategy combines broad parameter coverage with a price-service proposition attractive to expanding hospital systems. The company reports revenue across patient monitoring and life support as a broader business line rather than isolating sales of monitors and accessories.

Masimo Corporation

Masimo is differentiated by signal-processing and noninvasive measurement technologies, including SET pulse oximetry, O3 regional oximetry and the Root connectivity and monitoring platform. Its sensors create recurring revenue and are integrated into both Masimo systems and third-party monitors. Expanded FDA-cleared indications for O3 reinforce its strategy of extending optical measurements into higher-acuity decision support. Masimo does not publish a separate 2025 revenue figure solely for patient-monitoring devices and accessories, so product adoption and sensor utilization are more appropriate competitive indicators.

Recent Developments

• In October 2025, GE HealthCare announced CE marking for its Carevance patient monitor. The platform provides ECG, respiration and oxygen-saturation monitoring, intra-hospital transport workflow and Cardiac Output Insights, a software-based view designed to broaden access to perioperative hemodynamic assessment without additional proprietary invasive hardware.
• In September 2025, Philips introduced a telemetry platform centered on the wearable Telemetry Monitor 5500. The solution supports enterprise-wide cardiac monitoring, central-station integration, mobile clinical workflows, alarm analytics and retrospective review of telemetry use.
• At Euroanaesthesia 2025, Mindray introduced the BeneVision V Series patient monitoring system. The platform targets critical care and perioperative workflows and reflects the company’s continued expansion from value-oriented monitors into premium decision-support and enterprise integration.
• Masimo received FDA clearance for expanded indications associated with its O3 regional oximetry platform and delta hemoglobin parameters. The development broadens the clinical use of noninvasive optical monitoring in settings where changes in regional oxygenation and hemoglobin-related measurements can guide assessment.

Strategic Takeaways

• The market is forecast to add USD 54.86 billion between 2025 and 2035 as continuous surveillance expands from high-acuity beds into wards and homes.
• Hemodynamic monitoring controls 49.6% of revenue, but its scale depends heavily on glucose supplies and sensors as well as hospital cardiovascular monitoring.
• Accessories generate 32% of sales and should be evaluated through lifetime cost, compatibility, skin safety, cleaning and inventory requirements.
• Connected systems hold 61% of revenue, making interfaces, cybersecurity updates and patient-identity integrity decisive purchasing filters.
• Hospitals remain the largest end user at 55%, while homecare’s 24% share creates growth only when data review and reimbursement workflows are operational.
• North America leads with 42.8%; Asia-Pacific’s faster expansion will favor suppliers that pair competitive pricing with local service and regulatory coverage.
• Alarm reduction and clinical usability will outperform feature accumulation as staffing shortages push hospitals to measure workflow burden.

Why Purchase the Report?

• To visualize the global patient monitoring devices and accessories market segmentation based on product type, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of global patient monitoring devices and accessories market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in Excel consisting of key products of all the major players.

The global patient monitoring devices and accessories market report would provide approximately 51 tables, 54 figures, and 281 Pages.

Target Audience

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies